Recognition and of prescribing patterns associated with biologic medications for psoriasis is vital to understanding health care utilization and improving health systems practices for patients and providers, a new study found. Patients were classified as having psoriasis if they had 2 diagnosis codes for psoriasis, or 1 diagnosis for psoriasis and a subsequent prescription for a systemic psoriasis therapy or phototherapy on a separate day. Only patients with ≥1 prescription for a biologic medication were included. Among the findings:
- 34,714 eligible patients were included.
- The median time between first and last prescriptions was 3.3 - 7.0 months, depending on the drug.
- Up to half of patients that received a prescription for a biologic medication did not receive a second prescription for the same medication.
Noe MH, et al. Prescribing patterns associated with biologic therapies for psoriasis from a United States medical records database. J Drugs Dermatol. 2019;18(8):745-750.